Skip to main content
Search

Research Interviews

Launched April 2018 Updated March 2026 43 interviews
Summary

Listen to in-depth interviews with leading researchers as they explore fundamental discoveries, translational science, and emerging technologies shaping biomedical research. These conversations examine experimental approaches, mechanistic insights, and future directions across a wide range of scientific disciplines.

Play All talks in this series
Expand All  /  Collapse All

Biochemistry (1 Interview)  

Cancer/Oncology (8 Interviews)  

Audio Interview
From lab to clinic: bridging cancer genetics and public health
26 min
  • Prof. Clare Turnbull
  • Institute of Cancer Research, UK
Audio Interview
Engineered yeast: a breakthrough in targeted cancer therapies
21 min
  • Prof. Gautam Dantas
  • Washington University School of Medicine, St. Louis, USA
Audio Interview
Harnessing CCR2+ nonclassical monocytes to combat cancer metastasis
9 min
  • Dr. Ankit Bharat
  • Northwestern University, USA
Audio Interview
Cancer vaccines
18 min
  • Dr. Elias Sayour
  • University of Florida, USA
Audio Interview
The future of blood tests in cancer treatment
11 min
  • Dr. Isaac Garcia-Murillas
  • The Institute of Cancer Research, UK
Audio Interview
The development of therapeutic antibodies against oncogenic antigens
15 min
  • Prof. Ben Seon
  • Roswell Park Cancer Institute, USA
Audio Interview
Artificial intelligence in precision medicine
14 min
  • Dr. Michael P. Menden
  • ICB Institute of Computational Biology, Helmholtz Zentrum München, Germany
Audio Interview
How liver X receptor regulates intestinal regeneration and tumor growth
18 min
  • Dr. Srustidhar Das
  • Karolinska Institutet and University Hospital, Sweden

Immunology & Inflammation (5 Interviews)  

Infectious Diseases/Microbiology (4 Interviews)  

Methods (5 Interviews)  

Neurology/Neuroscience (8 Interviews)  

Audio Interview
Rethinking the amyloid dogma in Alzheimer’s disease
14 min
  • Prof. George Perry
  • The University of Texas at San Antonio, USA
Audio Interview
Integrated multimodal cell atlas of Alzheimer’s disease
8 min
  • Dr. Michael Hawrylycz
  • The Allen Institute, USA
Audio Interview
How and why neurons die in Alzheimer's disease?
17 min
  • Prof. Bart De Strooper
  • University College London, UK
Audio Interview
Restoring glucose metabolism: a new approach to reversing cognitive decline in AD
17 min
  • Prof. Katrin Andreasson
  • Stanford University, USA
Audio Interview
Advancing ALS genetics through accessible testing
18 min
  • Dr. Teresa Fecteau
  • Biogen, USA
Audio Interview
MicroRNA as a biomarker for early detection of amyotrophic lateral sclerosis
13 min
  • Dr. Sandra Banack,
  • Dr. Paul Alan Cox,
  • Dr. Rachael Dunlop
Audio Interview
Translational research in amyotrophic lateral sclerosis (ALS)
25 min
  • Prof. Aaron D. Gitler
  • Stanford University School of Medicine, USA
Audio Interview
Muscarinic acetylcholine receptor modulation in neurological diseases
20 min
  • Prof. Andrew B. Tobin
  • University of Glasgow, UK

Pharmaceutical Sciences (12 Interviews)  

Audio Interview
The state of the art in secondary pharmacology
19 min
  • Dr. Jean-Pierre Valentin
  • UCB, Belgium
Audio Interview
The safety, toxicology, and regulation of antibody-drug conjugates
19 min
  • Dr. Veysel Kayser
  • The University of Sydney, Australia
Audio Interview
Predictive modelling for cell culture processes in biotherapeutic manufacturing
18 min
  • Dr. Shyam Panjwani
  • Bayer Pharmaceuticals, USA
Audio Interview
Management of generic drug development: challenges and opportunities
31 min
  • Mr. Sandeep Patil
  • Helios Glanz Pte. Ltd., Singapore
Audio Interview
Translational medicine: the risk of failure in delay and how to reduce it
30 min
  • Prof. Martin Wehling
  • University of Heidelberg, Germany
Audio Interview
Artificial intelligence in guiding cancer treatment decisions
17 min
  • Prof. Eytan Ruppin
  • National Institutes of Health (NIH), USA
Audio Interview
The regulation of cell therapy
13 min
  • Prof. Moutih Rafei
  • University of Montreal, Canada
Audio Interview
Scale-up challenges in the production of nanomedicines from lab to industry
31 min
  • Prof. Dr. Oya Tagit
  • FHNW, Switzerland
Audio Interview
Challenges and solutions of scaling up
8 min
  • Dr. Shaukat Ali
  • Ascendia Pharmaceuticals, USA
Audio Interview
Integrating novel digital health technologies into clinical trials
11 min
  • Mr. Rinol Alaj
  • Regeneron, USA
Audio Interview
Using real-world insights on drug interactions to inform drug development
14 min
  • Dr. Amita Datta-Mannan
  • Eli Lilly, USA
Audio Interview
Role of marketing authorization holder in drug safety
50 min
  • Dr. Raphael Elmadjian Pareschi
  • Roche Pharmaceuticals, Brazil